a public good project by the
Synthesis
Company
of California

© 2026

Peter Rieckmann | doi.page

0 works0 citations0 h-index

Peter Rieckmann

Publications by Year

Research Areas

Multiple Sclerosis Research Studies, Peripheral Neuropathies and Disorders, Polyomavirus and related diseases, Chronic Lymphocytic Leukemia Research, Rheumatoid Arthritis Research and Therapies

Most-Cited Works

→ A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis(2010)988 cited
→ Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters(2002)624 cited
→ Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial(2009)587 cited
→ Monocyte/macrophage differentiation in early multiple sclerosis lesions(1995)523 cited
PRISMS-4: Long-term efficacy of interferon-beta-1a in relapsing MS(2001)
→ Endothelins, peptides with potent vasoactive properties, are produced by human macrophages.(1990)458 cited
→ CNTF is a major protective factor in demyelinating CNS disease: A neurotrophic cytokine as modulator in neuroinflammation(2002)401 cited

→ Tumor necrosis factor‐α messenger RNA expression in patients with relapsing‐remitting multiple sclerosis is associated with disease activity(1995)336 cited

→ Safety and efficacy of cladribine tablets in patients with relapsing–remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study(2017)321 cited

→ New perspectives in the natural history of multiple sclerosis(2010)257 cited